Markets Surge on Shutdown Breakthrough

Markets Surge as Senate Moves to End Government Shutdown

Risk rallied as the Senate advanced a deal to end the historic U.S. shutdown. Tech outperformed, M&A popped, and U.S.–China talks eased supply risks.

TL;DR:

🏛️ Senate moves to end U.S. shutdown
💻 Tech leads relief rally on headlines
💊 Pfizer buys Metsera in $10B deal
🌏 U.S.-China thaw on fentanyl, rare earths

Senate Moves to End U.S. Shutdown

U.S. stocks ripped higher after the Senate advanced funding measures aimed at ending the historic government shutdown, easing policy risk and lifting sentiment across cyclicals and credit. The relief bid pressured havens while supporting risk-on positioning into the close. Traders looked for confirmation from the House and timing on a final vote. Source

Tech Stocks Lead Relief Rally

Megacap tech paced gains as shutdown uncertainty faded and yields steadied, with semis and software outperforming. Breadth improved as dip buyers stepped back in, while momentum names reclaimed short-term trend lines. Focus shifts to follow-through and whether volume confirms leadership. Source

Pfizer Strikes $10B Metsera Deal

Pfizer agreed to acquire obesity drug developer Metsera for roughly $10 billion, extending the weight-loss arms race and re-rating obesity pipelines across healthcare. The deal adds optionality to Pfizer’s metabolic portfolio and lifted peer sentiment in anti-obesity therapeutics. Watch for integration timelines and regulatory milestones. Source

U.S.-China Thaw Eases Supply Tensions

Washington and Beijing held constructive talks on fentanyl enforcement and rare earth exports, improving the macro tone and easing supply-chain anxiety. The dialogue supported semis and EV materials while trimming risk premia tied to trade frictions. Sustainably lower volatility hinges on policy follow-through. Source

Markets Surge as Senate Moves to End Government Shutdown